BioSciKin
No. 218 Xinghu Street, Room B2-406, Biological Nano Park, Suzhou Industrial Park, Suzhou, Jiangsu, China
Overview
BioSciKin is open platform for life science entrepreneurs and innovations.Its a pharmaceutical enterprise andresearch institute.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Association
- Biotechnology
- Education
- Health Care
- Pharmaceutical
Investment portfolio
- Applied StemCell
Participated · Series D · Jun 2016
Applied StemCell (ASC) develops gene-editing platforms and therapeutics enabled by its proprietary TARGATT™ and CRISPR/Cas9 technologies. The company produces enabling tools and leverages genome editing for animal and cell model generation. ASC says it is building a therapeutic pipeline with a strong focus on monogenic blood disorders and high genetic-penetrance diseases. It also emphasizes expanding and strengthening its intellectual property portfolio around improved genome-editing technologies. Management frames the work as enabling scientific discovery and advancing human medicine through both products and therapeutics. The company is based in Milpitas, California.
Team
No current team members are available.